Chicago Partners Investment Group’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $441K | Buy |
163,766
+47,201
| +40% | +$127K | 0.01% | 652 |
|
|
2025
Q1 | $221K | Buy |
116,565
+521
| +0.4% | +$990 | 0.01% | 825 |
|
|
2024
Q4 | $224K | Sell |
116,044
-2,131
| -2% | -$4.11K | 0.01% | 776 |
|
|
2024
Q3 | $233K | Buy |
118,175
+1,270
| +1% | +$2.5K | 0.01% | 706 |
|
|
2024
Q2 | $263K | Sell |
116,905
-8,379
| -7% | -$18.9K | 0.01% | 630 |
|
|
2024
Q1 | $317K | Sell |
125,284
-9,567
| -7% | -$24.2K | 0.01% | 558 |
|
|
2023
Q4 | $198K | Buy |
134,851
+23,740
| +21% | +$34.9K | 0.01% | 663 |
|
|
2023
Q3 | $242K | Buy |
+111,111
| New | +$242K | 0.01% | 559 |
|